发明公开
EP3106175A1 NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
审中-公开
新型免疫疗法针对不同肿瘤,包括神经和脑肿瘤
- 专利标题: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
- 专利标题(中): 新型免疫疗法针对不同肿瘤,包括神经和脑肿瘤
-
申请号: EP16179163.7申请日: 2009-09-28
-
公开(公告)号: EP3106175A1公开(公告)日: 2016-12-21
- 发明人: Schoor, Oliver , Hilf, Norbert , Weinschenk, Toni , Trautwein, Claudia , Walter, Steffen , Singh, Harpreet
- 申请人: Immatics Biotechnologies GmbH
- 申请人地址: Paul-Ehrlich-Strasse 15 72076 Tübingen DE
- 专利权人: Immatics Biotechnologies GmbH
- 当前专利权人: Immatics Biotechnologies GmbH
- 当前专利权人地址: Paul-Ehrlich-Strasse 15 72076 Tübingen DE
- 代理机构: Krauss, Jan
- 优先权: EP08017305 20081001; EP08017921 20081013; US105928P 20081016
- 主分类号: A61K39/00
- IPC分类号: A61K39/00 ; A61P35/00 ; A61K38/08 ; A61K38/16
摘要:
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 30 peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
公开/授权文献
信息查询